Skip to main content
. 2023 Sep 5;63(6):1656–1663. doi: 10.1093/rheumatology/kead461

Table 4.

Clinical evidence regarding treatment with TNF blockade in AOSD

Authors Drug Design No. of patients Reference
Suematsu et al. Infliximab, etanercept Retrospective multicentre 13 [27]
Kraetsch et al. Infliximab Prospective pilot 6 [31]
Fautrel et al. Infliximab, etanercept Restrospective multicentre 20 [32]
Dilhuydy et al. Infliximab Case report 1 [33]
Zhou et al. Infliximab, etanercept, adalimumab Retrospective multicentre 293 [34]
Babacan et al. Infliximab Case report 1 [35]
Maeshima et al. Etanercept Case report 1 [55]
Naniwa et al. Etanercept Case report 1 [56]
Singh et al. Infliximab Case report 1 [57]

AOSD: adult-onset Still’s disease.